June 9th - 12th, 2015
Palais Universitaire
Strasbourg, France

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets.

However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of the time, it is the topic of a specialised session within drug discovery conferences, and on the other hand biophysical meetings are often very academy-oriented and rarely extend their scope to drug discovery aspects.

Bringing together the medchem and biophysics communities, the conference, with a 2/1 ratio of participants from industry / academia, was a dense and rich event with lively discussions after presentations, around the posters and during the round table.

The 2nd NovAliX Conference Biophysics in Drug Discovery 2015 intends to further develop the synergy between biophysics and medicinal chemistry, which is key to deliver better drugs on a shorter timeline. The following topics will be discussed during the conference:

• Method Development & Emerging Technologies
• Biophysics for Integral Membrane Proteins
• Impact of Biophysics on Drug Discovery Projects
• Use of Kinetics in Drug Discovery
• Epigenetics (Special Focus of the conference)

Iris Biotech GmbH will participate at the 2nd NovAliX Conference Biophysics in Drug Discovery 2015 in Strasbourg and we would be glad to meet you there.